Skip to main content
SpringerLink
Log in

Do fast-track appraisals for low-ICER treatments add up?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Carroll C, et al. What Is the Evidence from Past National Institute of Health and Care Excellence Single-Technology Appraisals Regarding Company Submissions with Base-Case Incremental Cost-Effectiveness Ratios of Less Than GBP10,000/QALY? Value in Health : Oct 2017. Available from: URL: https://doi.org/10.1016/j.jval.2017.09.006

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Do fast-track appraisals for low-ICER treatments add up?. PharmacoEcon Outcomes News 790, 10 (2017). https://doi.org/10.1007/s40274-017-4455-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4455-0

Search

Navigation